Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes

By sjmartinez • November 29, 2024

Vale C, Lourenço IM, Jordan G, Golovaty I, Torres H, Moin T, Buysschaert M, Neves JS, Bergman M. Early combination therapy with SGLT2i and GLP-1 RA or dual GIP/GLP-1 RA in type 2 diabetes. Diabetes Obes Metab. 2024 Nov 27. doi: 10.1111/dom.16077. Epub ahead of print. PMID: 39604324.

Tags: combination therapy, dual GIP/GLP‐1 receptor agonists, Endocrinology, GLP‐1 receptor agonists, Publications, SGLT2 inhibitors, Type 2 diabetes

Menopause factors and alterations in gut microbiota and insulin homeostasis: A cross-sectional analysis of the microbiome and insulin longitudinal evaluation study (MILES)

Maffei VJ, Bertoni AG, Wood AC, Rotter JI, Crago O, Chen YI, Petrosino JF, Hoffman KL, Goodarzi MO, Jensen ET. Menopause factors and alterations in[...]

Pubertal mediators of early life stress and age on adolescent alcohol initiation: Analysis by sex

Donovan A, Assari S, Grella C, Shaheen M, Richter L, Friedman TC. Pubertal mediators of early life stress and age on adolescent alcohol initiation: Analysis[...]

Deletion of PTP1B in cardiomyocytes alters cardiac metabolic signaling to protect against cardiomyopathy induced by a high-fat diet

Sun Y, Mishra AK, Chanrasekhar V, Door M, Kessinger CW, Xu B, Tang P, Gao Y, Kamli-Salino S, Nelson K, Delibegovic M, Abel ED, Kirk[...]